Explore the role of computerized systems used in clinical investigations to improve efficiency and data integrity.
Introduction The regulatory landscape governing computerized systems in clinical investigations is undergoing a profound evolution, shaped by stringent guidelines from authorities such as the Food and Drug Administration (FDA) and the International Conference on Harmonisation (ICH). Central to this framework is 21 CFR Part 11, which establishes critical requirements for electronic records and signatures, ensuring data integrity and security. As medical device startups navigate these complex regulations, understanding the implications of compliance becomes paramount for successful clinical trials. This article delves into the multifaceted world of computerized systems in clinical investigations, exploring their types, benefits, challenges, and future trends. It highlights how these systems not only enhance research efficiency and data accuracy but also play a pivotal role in shaping the future of clinical trials amidst evolving technological advancements. Regulatory Framework for Compu…